AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N93024C00051GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.
Overview
Award facts
- Net obligations
- $6.69M
- $6,685,998of $9.67M potential value
- Outlays (paid to date)
- $2.08M
- $2.08M paid of $6.69M obligated$2,078,742
- Period of performance
- Sep 18, 2024 to Jun 18, 2027
- Ends in 7 months
- Modifications
- 4
- Latest action Jul 29, 2026
- Contract type
- Definitive contract
- PIID 75N93024C00051
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
BAA2023-1 RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES
Dates and value
- Award date
- Signed on Sep 12, 2024
- Potential end of performance
- Sep 4, 2029
- Current value
- $6,685,998Base and exercised options
- Potential value (if all options are exercised)
- $9,673,642
Obligations by fiscal year of action
- FY2026: $2,474,025
- FY2024: $4,211,973
Total across 2 fiscal years: $6,685,998
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 29, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationNISKAYUNA, NY
UEIG2JTZ3UQV9M3
CAGE code9G8T4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyGE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Schenectady, New York 12309-1027
- Congressional district (place of performance)
- NY-20As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost no feeS
- Offers received
- 10
Solicitation and notices
- Solicitation ID
- HHS-NIH-NIAID-BAA2023-1
- Solicitation date
- Jan 11, 2023
- Notices
- Award Notice posted May 9, 2024
- Award Notice posted Sep 19, 2023
- Award Notice posted Sep 19, 2023
- Solicitation posted Apr 7, 2023
- Solicitation posted Apr 6, 2023
- Solicitation posted Apr 3, 2023
- Solicitation posted Mar 28, 2023
- Solicitation posted Mar 21, 2023
- Solicitation posted Mar 10, 2023
- Solicitation posted Mar 3, 2023
Contract details
- Subcontracting plan
- Individual subcontract planF
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 12, 2024Base obligation at award: $4,211,973
- Latest action
- Jul 29, 2026 — Other administrative actionModification P00004; administrative: no change in scope or value
- Latest substantive action
- Jun 17, 2026 — Option exercisedModification P00003; obligation change +$2,474,025
- Actions by type
- Base award1
- Other administrative action3
- Option exercised1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2024/2024-0885-000
- 075-2026/2026-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression